Author:
Andrić Biljana,Radonjić Zorica,Šerbić Olivera,Vujić Dragana,Zečević Željko,Simić Marija,Gobeljić Borko,Jovanović-Srzentić Snežana,Radović Ivana
Abstract
<b><i>Introduction:</i></b> ABO blood type changes after ABO-incompatible hematopoietic stem cell transplantation (HSCT). Most non-hematopoietic tissues retain the expression of the patient’s own ABO antigens, which may adsorb from the plasma onto the donor’s red blood cells (RBCs). Because of this phenomenon, a persistent patient’s A and/or B antigen could be detected in the laboratory, despite 100% white cell donor chimerism. Adsorption of the patient’s soluble ABO antigens on the newly formed RBCs complicates the interpretation of the patient’s blood type and decision of transfusion therapy. <b><i>Case Presentation:</i></b> The first case report is a 6-year-old girl, A, D+, with T-cell acute lymphoblastic leukemia (ALL), transplanted with HLA-matched unrelated group O, D+ bone marrow. A second case report describes an 8-year-old girl, AB, D−, with ALL transplanted with an HLA-matched related group B, D+ bone marrow. The presence of persistent antigen A was registered in both patients more than 1 year after HSCT, despite complete donor chimerism. <b><i>Conclusion:</i></b> The weak expression of ABO antigens on RBCs after HSCT should be examined in detail for proper planning of transfusion therapies.